1. Keeley, Ellen C, Blotner, Michael R, Lipson, Lewis C, Mehrad, Borna. 2022. CXCL5 gene polymorphisms and coronary collateralization. In American heart journal plus : cardiology research and practice, 23, 100220. doi:10.1016/j.ahjo.2022.100220. https://pubmed.ncbi.nlm.nih.gov/38560656/
2. Zhao, Jingkun, Ou, Baochi, Han, Dingpei, Feng, Hao, Lu, Aiguo. 2017. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. In Molecular cancer, 16, 70. doi:10.1186/s12943-017-0629-4. https://pubmed.ncbi.nlm.nih.gov/28356111/
3. Park, Seong-Eun, Park, Kanghyun, Kim, Eungyung, Kim, Myoung Ok, Kim, Yong-Gun. 2024. CXCL5/CXCL8 induces neutrophilic inflammation in peri-implantitis. In Journal of periodontal research, 59, 698-711. doi:10.1111/jre.13230. https://pubmed.ncbi.nlm.nih.gov/38699841/
4. Hasani Ranjbar, Shirin, Amiri, Parvin, Zineh, Issam, Larijani, Bagher, Amoli, Mahsa M. . CXCL5 gene polymorphism association with diabetes mellitus. In Molecular diagnosis & therapy, 12, 391-4. doi:. https://pubmed.ncbi.nlm.nih.gov/19035625/
5. Sun, Dantong, Tan, Lipin, Chen, Yongbing, Xu, Weihua, Shen, Mingjing. 2024. CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis. In Journal of experimental & clinical cancer research : CR, 43, 202. doi:10.1186/s13046-024-03122-8. https://pubmed.ncbi.nlm.nih.gov/39034411/